Clinical Trial Update: Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating carboplatin in early triple-negative breast cancer (PEARLY Trial) is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Yonsei University | Conditions: Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING